GB Sciences, Inc. – OTC:GBLX
GB Sciences stock price today
GB Sciences stock price monthly change
GB Sciences stock price quarterly change
GB Sciences stock price yearly change
GB Sciences key metrics
Market Cap | 7.97M |
Enterprise value | 7.86M |
P/E | -0.89 |
EV/Sales | N/A |
EV/EBITDA | -1.71 |
Price/Sales | N/A |
Price/Book | -4.18 |
PEG ratio | -0.01 |
EPS | -0.01 |
Revenue | N/A |
EBITDA | -1.15M |
Income | -6.03M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGB Sciences stock price history
GB Sciences stock forecast
GB Sciences financial statements
| Mar 2023 | 0 | -5.13M | |
|---|---|---|---|
| Jun 2023 | 0 | -273.12K | |
| Sep 2023 | 0 | -434.23K | |
| Dec 2023 | 0 | -187.27K |
| Payout ratio | 0% |
|---|
| 2016 | |
|---|---|
| 2017 | |
| 2019 | 7893609.14% |
| 2020 | |
| 2022 |
| Dec 2022 | 2791926 | 4.40M | 157.73% |
|---|---|---|---|
| Jun 2023 | 229203 | 4.90M | 2142.08% |
| Sep 2023 | 234185 | 4.92M | 2104.03% |
| Dec 2023 | 147114 | 4.99M | 3394.77% |
| Mar 2023 | -219.89K | -31.64B | 55.76K |
|---|---|---|---|
| Jun 2023 | -105.30K | 0 | 25K |
| Sep 2023 | -412.52K | 235K | 252.44K |
| Dec 2023 | -205.40K | 85K | 33.33K |
GB Sciences alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
GB Sciences other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2017 | 0 | 100000 |
| Jul 2018 | 99964 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | POSS JOHN C director, officer.. | Common Stock | 11,915 | $0.42 | $4,945 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 3,615 | $0.41 | $1,493 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 30,000 | $0.41 | $12,150 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 23,184 | $0.4 | $9,274 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 10,000 | $0.4 | $4,000 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 20,000 | $0.41 | $8,200 | ||
Purchase | POSS JOHN C director, officer.. | Common Stock | 1,250 | $0.41 | $508 | ||
Sale | ELLINS CRAIG other: Former officer and direc.. | Common Stock | 30,000 | $0.26 | $7,650 | ||
Sale | ELLINS CRAIG other: Former officer and direc.. | Common Stock | 20,000 | $0.26 | $5,100 | ||
Sale | ELLINS CRAIG other: Former officer and direc.. | Common Stock | 50,000 | $0.26 | $12,750 |
| Insider | Compensation |
|---|---|
Mr. Zach Swarts (1988) Chief Financial Officer, Chief Accounting Officer & Treasurer | $127,500 |
Dr. Andrea Small-Howard M.B.A., Ph.D., MBA (1969) Pres, Member of Scientific Advisory Board, Chief Science Officer & Director | $99,000 |
| Mr. John C. Poss (1948) Chairman & Chief Executive Officer | $74,500 |
-
What's the price of GB Sciences stock today?
One share of GB Sciences stock can currently be purchased for approximately $0.
-
When is GB Sciences's next earnings date?
Unfortunately, GB Sciences's (GBLX) next earnings date is currently unknown.
-
Does GB Sciences pay dividends?
No, GB Sciences does not pay dividends.
-
How much money does GB Sciences make?
GB Sciences has a market capitalization of 7.97M.
-
What is GB Sciences's stock symbol?
GB Sciences, Inc. is traded on the OTC under the ticker symbol "GBLX".
-
What is GB Sciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of GB Sciences?
Shares of GB Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are GB Sciences's key executives?
GB Sciences's management team includes the following people:
- Mr. Zach Swarts Chief Financial Officer, Chief Accounting Officer & Treasurer(age: 37, pay: $127,500)
- Dr. Andrea Small-Howard M.B.A., Ph.D., MBA Pres, Member of Scientific Advisory Board, Chief Science Officer & Director(age: 56, pay: $99,000)
- Mr. John C. Poss Chairman & Chief Executive Officer(age: 77, pay: $74,500)
-
How many employees does GB Sciences have?
As Jul 2024, GB Sciences employs 3 workers.
-
When GB Sciences went public?
GB Sciences, Inc. is publicly traded company for more then 21 years since IPO on 30 Dec 2003.
-
What is GB Sciences's official website?
The official website for GB Sciences is gbsciences.com.
-
Where are GB Sciences's headquarters?
GB Sciences is headquartered at 3550 West Teco Avenue, Las Vegas, NV.
-
How can i contact GB Sciences?
GB Sciences's mailing address is 3550 West Teco Avenue, Las Vegas, NV and company can be reached via phone at +86 67210297.
GB Sciences company profile:
GB Sciences, Inc.
gbsciences.comOTC
3
Biotechnology
Healthcare
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
Las Vegas, NV 89118
CIK: 0001165320
ISIN: US3615441090
CUSIP: 361544109
